Close

SVB Leerink Downgrades Biohaven Pharmaceutical Holding (BHVN) to Market Perform

May 11, 2022 4:08 AM EDT Send to a Friend
SVB Leerink analyst Marc Goodman downgraded Biohaven Pharmaceutical Holding (NYSE: BHVN) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login